Vimarsana
Biggest News Aggregation in the World

Page 12 - Interim Orders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interim Orders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interim Orders Today - Breaking & Trending Today

Pharma In Brief: The 2020 Year In Review - Food, Drugs, Healthcare, Life Sciences - Vimarsana News

Pharma In Brief: The 2020 Year In Review - Food, Drugs, Healthcare, Life Sciences

CSPs). (a) COVID-19 In response to the COVID-19 pandemic, the federal government pursued Interim Orders and other policy changes intended to expedite the development of COVID-19-related products, including drugs, vaccines, hand sanitizers, disinfectants, personal protective equipment, and medical devices (see e.g., here and here). Both the federal and provincial governments made regulatory changes to secure domestic drug supplies and mitigate shortages (see e.g., here and here). Many of these policies were passed on an interim basis but still remain in effect. Patent Act, adding a provision...

Source: mondaq.com
2020 Highlights In Canadian Life Sciences IP And Regulatory Law - Food, Drugs, Healthcare, Life Sciences - Vimarsana News

2020 Highlights In Canadian Life Sciences IP And Regulatory Law - Food, Drugs, Healthcare, Life Sciences

In response to the pandemic, we saw quick action and flexibility from: the Canadian Intellectual Property Office (CIPO) - deadlines from March 16 to August 28 were extended until August 31. On December 14, the Trademarks Office began accepting requests for expedited examination of trademark applications associated with medical goods or services related to COVID-19; the Federal Courts - Federal Court (FC) deadlines were suspended until June 29 or July 13, depending on the province, and a number of hearings and patent trials were conducted by Zoom.  Federal Court of Appeal (FCA) deadlines co...

Source: mondaq.com
2020 Highlights in Canadian Life Sciences IP and Regulatory Law | Smart & Biggar - Vimarsana News

2020 Highlights in Canadian Life Sciences IP and Regulatory Law | Smart & Biggar

1. COVID-19: CIPO, Federal Courts, Health Canada In response to the pandemic, we saw quick action and flexibility from: the Canadian Intellectual Property Office (CIPO) – deadlines from March 16 to August 28 were extended until August 31. On December 14, the Trademarks Office began accepting requests for expedited examination of trademark applications associated with medical goods or services related to COVID-19; the Federal Courts – Federal Court (FC) deadlines were suspended until June 29 or July 13, depending on the province, and a number of hearings and patent trials were conducted ...